These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24572042)

  • 21. Effects of cognitive emotion regulation strategies on mood and cortisol in daily life in women with premenstrual dysphoric disorder.
    Nayman S; Beddig T; Reinhard I; Kuehner C
    Psychol Med; 2023 Aug; 53(11):5342-5352. PubMed ID: 35979813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.
    Miller KN; Standeven L; Morrow AL; Payne JL; Epperson CN; Hantsoo L
    Psychoneuroendocrinology; 2024 Feb; 160():106684. PubMed ID: 38091917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The late-luteal leptin level, caloric intake and eating behaviors among women with premenstrual dysphoric disorder.
    Ko CH; Yen CF; Long CY; Kuo YT; Chen CS; Yen JY
    Psychoneuroendocrinology; 2015 Jun; 56():52-61. PubMed ID: 25800149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.
    Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31703451
    [No Abstract]   [Full Text] [Related]  

  • 26. Facial emotion discrimination across the menstrual cycle in women with premenstrual dysphoric disorder (PMDD) and controls.
    Rubinow DR; Smith MJ; Schenkel LA; Schmidt PJ; Dancer K
    J Affect Disord; 2007 Dec; 104(1-3):37-44. PubMed ID: 17367867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empathy-related abnormalities among women with premenstrual dysphoric disorder: clinical and functional magnetic resonance imaging study.
    Lerner Y; Raz G; Bloch M; Krasnoshtein M; Tevet M; Hendler T; Tene O
    BJPsych Open; 2024 Aug; 10(5):e138. PubMed ID: 39101206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.
    Kask K; Gulinello M; Bäckström T; Geyer MA; Sundström-Poromaa I
    Neuropsychopharmacology; 2008 Aug; 33(9):2283-90. PubMed ID: 17940552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gonadotrophic hormone and reinforcement sensitivity systems in women with premenstrual dysphoric disorder.
    Ko CH; Long CY; Yen CF; Chen CS; Wang PW; Yen JY
    Psychiatry Clin Neurosci; 2014 Nov; 68(11):785-94. PubMed ID: 24735107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating biological rhythms disruptions across the menstrual cycle in women with comorbid bipolar disorder and premenstrual dysphoric disorder.
    El Dahr Y; de Azevedo Cardoso T; Syan SK; Caropreso L; Minuzzi L; Smith M; Allega OR; El-Tayebani M; Mendes-Ribeiro J; de Mattos Souza LD; da Silva RA; Mondin TC; Moreira FP; Kapczinski F; Jansen K; Frey BN
    Arch Womens Ment Health; 2022 Apr; 25(2):345-353. PubMed ID: 35226173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resting-state functional connectivity in women with PMDD.
    Petersen N; Ghahremani DG; Rapkin AJ; Berman SM; Wijker N; Liang L; London ED
    Transl Psychiatry; 2019 Dec; 9(1):339. PubMed ID: 31827073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
    Oral E; Kirkan TS; Yildirim A; Kotan Z; Cansever Z; Ozcan H; Aliyev E; Gulec M
    Gen Hosp Psychiatry; 2015; 37(3):266-72. PubMed ID: 25799087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
    Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M
    Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of premenstrual dysphoric disorder with the GABA
    Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
    Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insomnia, Inattention and Fatigue Symptoms of Women with Premenstrual Dysphoric Disorder.
    Lin PC; Ko CH; Lin YJ; Yen JY
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34201084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered visual cortex excitability in premenstrual dysphoric disorder: Evidence from magnetoencephalographic gamma oscillations and perceptual suppression.
    Manyukhina VO; Orekhova EV; Prokofyev AO; Obukhova TS; Stroganova TA
    PLoS One; 2022; 17(12):e0279868. PubMed ID: 36584199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptin and ghrelin concentrations and eating behaviors during the early and late luteal phase in women with premenstrual dysphoric disorder.
    Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
    Psychoneuroendocrinology; 2020 Aug; 118():104713. PubMed ID: 32460195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder.
    Thys-Jacobs S; McMahon D; Bilezikian JP
    J Clin Endocrinol Metab; 2008 Jan; 93(1):96-102. PubMed ID: 17956950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nociceptive processing in women with premenstrual dysphoric disorder (PMDD): the role of menstrual phase and sex hormones.
    Bartley EJ; Palit S; Kuhn BL; Kerr KL; Terry EL; DelVentura JL; Rhudy JL
    Clin J Pain; 2015 Apr; 31(4):304-14. PubMed ID: 24810651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.